Asia · Regional markets · The Financial Express

Zydus Lifesciences’ menopause drug eligible for 180-day US market exclusivity

Published by The Financial Express · India 9 h ago

Read how Zydus won USFDA approval for a generic Climara Pro menopause patch, with possible 180-day exclusivity in a $45.7M US market.

Read the full article on The Financial Express Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.financialexpress.com)

Also worth reading

Aditya Birla Sun Life AMC Q2 Results: Market share continues to drop, higher costs impact margins

The Straits Times Business

OCBC to let customers hold Malaysian ringgit in Singapore savings accounts from Oct 23

Business Standard

Vishal Mega Mart falls 6% as festive shift weighs on margins, SSSG in Q2

The Business Times

Indonesia’s central bank keeps main rate unchanged but hikes deposit facility rate, to cut RRR

Pulse (Maeil Business)

NPS tightens voting rules on companies’ treasury stock plans

China Daily Business

Canton Fair sees high-tech flourish